Felbamate (Cadila Healthcare Limited)


Welcome to the PulseAid listing for the Felbamate drug offered from Cadila Healthcare Limited. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cadila Healthcare Limited
NON-PROPRIETARY NAME: Felbamate
SUBSTANCE NAME: FELBAMATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-08-15
END MARKETING DATE: 0000-00-00


Felbamate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFelbamate from Cadila Healthcare Limited
LABELER NAME: Cadila Healthcare Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 2017-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70771-1077_54e4d1c3-cf8c-4fff-8280-8edcb484c76e
PRODUCT NDC: 70771-1077
APPLICATION NUMBER: ANDA208970

Other FELBAMATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Felbamate
Amneal Pharmaceuticals LLCFelbamate
Cadila Healthcare LimitedFelbamate
Carilion Materials ManagementFelbamate
CorePharma, LLCFelbamate
Impax GenericsFelbamate
Marlex Pharmaceuticals IncFelbamate
Meda Pharmaceuticals Inc.Felbatol
Mylan Pharmaceuticals Inc.Felbamate
Taro Pharmaceuticals U.S.A., Inc.Felbamate
Taro Pharmaceuticals U.S.A., inc.Felbamate
Wallace Pharmaceuticals Inc.Felbamate
Zydus Pharmaceuticals (USA) Inc.Felbamate